Work

POSTER: CML-305 Discovery of a Selective PROTAC Degrading Untamable BCR::ABL1 Compound Mutants in Chronic Myelogenous Leukemia (CML)and Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)

Year: 2023

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(23)00545-1

Authors: Milad Rouhimoghadam, Hua Tang, Briana Bates, Junzhuo Liao, Daniela Uribe-Cano, Weiping Tang, Michael Deininger

Institutions: Versiti Blood Research Institute Foundation, University of Wisconsin–Madison

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4386301299

FWCI:

Cites:

Cited by:

Related to: 10